“…The suitable approach, mostly used, was to identify disease-related differences in miRNA expression by miRNA microarray or second-generation sequencing in small subgroups, followed by the validation by qRT-PCR on a larger sample size [ 8 , 9 , 13 , 14 , 16 , 23 – 25 , 31 , 34 , 53 , 58 ]. However, other studies just used qRT-PCR techniques to validate candidate biomarkers identified through literature search or based on previous findings [ 10 , 11 , 18 , 26 , 51 , 52 , 54 , 55 , 57 ]. In addition, variability between studies was also observed in data reporting.…”